Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Expansion of previous recall of AcrySof IQ ReSTOR and AcrySof IQ ReSTOR Toric IOL; now to include AcrySof IQ Toric models SN6AT6, SN6AT7, SN6AT8, and SN6AT9. Intended for primary implantation in the capsular bag of the eye for visual correction.

FDA Recall Z-0271-2016 · Posted 2015-11-25

Recalling FirmAlcon Research, Ltd.
Recall StatusTerminated
Product CodeHQL
Date Initiated2015-09-29
Date Terminated2017-06-30
Product Quantity43,651 units

Reason for Recall

Continued increase in reports of post-operative inflammation in patients who received AcrySof IQ Toric IOL.

Firm Action

The firm, Alcon, sent an "FDA Notification-Update to Recall Z-2323-2015" letter, dated October 1, 2015, to its Consignee in Japan who have received AcrySof IQ Toric IOL models SN6AT6 to SN6AT9 in order to initiate the recovery of product. The letter described the product, problem and actions to be taken. The consignee was instructed to stop using these immediately and put on hold until sales representatives visit their site for withdrawal. Recall does not affect AcrySof IQ Monofocal IOLs or AcrySof IQ Toric IOL models SN6AT3, SN6AT4 and SN6AT5.

Root Cause

Process design

Distribution Pattern

International Only Distribution -- Japan.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑